日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Wu et al. WIP1 Inhibition by GSK2830371 Potentiates HDM201 Through Enhanced p53 Phosphorylation and Activation in Liver Adenocarcinoma Cells. Cancers 2021, 13, 3876

更正：Wu 等人，《GSK2830371 对 WIP1 的抑制作用通过增强肝腺癌细胞中 p53 的磷酸化和激活来增强 HDM201 的作用》，Cancers 2021, 13, 3876

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18030530
Wu, Chiao-En; Mahdi, Ahmed Khairallah; Huang, Chen-Yang; Chen, Chiao-Ping; Pan, Yi-Ru; Chang, John Wen-Cheng; Chen, Jen-Shi; Yeh, Chun-Nan; Lunec, John
肿瘤
肿瘤免疫
信号转导
磷酸化
细胞生物学
发表日期：2026
文献求助 收藏

Nivolumab plus chemotherapy in Asian people with advanced or recurrent stomach or gastroesophageal junction cancer (ATTRACTION-4 study): a plain language summary

纳武利尤单抗联合化疗治疗亚洲晚期或复发性胃癌或胃食管交界处癌患者（ATTRACTION-4 研究）：简明语言摘要

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2026.2622806
Chen, Li-Tzong; Kang, Yoon-Koo; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Chung, Ik-Joo; Yamaguchi, Kensei; Kato, Ken; Sym, Sun Jin; Kadowaki, Shigenori; Tsuji, Kunihiro; Chen, Jen-Shi; Bai, Li-Yuan; Oh, Sung-Yong; Choda, Yasuhiro; Yasui, Hisateru; Takeuchi, Kentaro; Hirashima, Yoshinori; Hagihara, Shunsuke; Boku, Narikazu
胃癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Role of Sense of Coherence in Mediating the Relationship Between End-of-Life Caregiving Burden and Bereavement Depressive-Symptom Trajectory

连贯感在临终关怀负担与丧亲抑郁症状轨迹关系中的中介作用

期刊:Journal of Nursing Research
影响因子:2.5
doi:10.1097/jnr.0000000000000731
Wen, Fur-Hsing; Chou, Wen-Chi; Hou, Ming-Mo; Su, Po-Jung; Shen, Wen-Chi; Chen, Jen-Shi; Chang, Wen-Cheng; Tang, Siew Tzuh
抑郁症
神经科学
发表日期：2026
文献求助 收藏

Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.

台湾胃肠胰神经内分泌肿瘤的临床结果：一项多中心注册研究——TCOG T1214 研究

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.70019
Tsai Hui-Jen, Chen Ming-Huang, Wang Hsiu-Po, Hsiao Chin-Fu, Chen Yen-Yang, Chen Jen-Shi, Yang Mei-Due, Tzen Chin-Yuan, Shan Yan-Shen, Bai Li-Yaun, Chan De-Chuan, Chu Pei-Yi, Ho Ching-Liang, Yang Youngsen, Lin Johnson, Lin Hsuan-Yu, Chang Cheng-Shyong, Wang Chuan-Cheng, Hwang Tsann-Long, Chen Li-Tzong
免疫/内分泌
神经科学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Real-world effectiveness and prognostic factors of durvalumab plus chemotherapy in a multicentric cohort with advanced biliary tract cancer

在多中心队列研究中，度伐利尤单抗联合化疗治疗晚期胆道癌的真实世界疗效及预后因素

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae306
Huang, Wen-Kuan; Tang, Yan-Jei; Wu, Chiao-En; Hou, Ming-Mo; Hsu, Hung-Chih; Su, Po-Jung; Chiang, Nai-Jung; Chen, San-Chi; Yeh, Chun-Nan; Chen, Jen-Shi; Chen, Ming-Huang; Hsieh, Chia-Hsun; Chou, Wen-Chi
肿瘤
胆管癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Patient-caregiver concordance on death preparedness over Taiwanese cancer patients' last 6 months

台湾癌症患者临终前6个月中，患者与照护者对死亡准备的一致性

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae353
Wen, Fur-Hsing; Hsieh, Chia-Hsun; Chou, Wen-Chi; Chen, Jen-Shi; Chang, Wen-Cheng; Tang, Siew Tzuh
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan

香港和台湾地区在常规临床实践中应用兰瑞肽缓释凝胶治疗胃肠胰神经内分泌肿瘤（GEP-NETs）患者的真实世界研究

期刊:Oncology and Therapy
影响因子:3.2
doi:10.1007/s40487-024-00302-6
Chen, Jen-Shi; Bai, Li-Yuan; Cheng, Hsiao-Hsiang; Chan, Stephen Lam; Zou, Ji-Yan; Shi, Xiaofeng; Houchard, Aude; Truong-Thanh, Xuan-Mai; Chen, Ming-Huang
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Validation of WHO 2017 Classification and Identification of Prognostic Factors in Patients with Pancreatic Neuroendocrine Neoplasms: A Real-World Experience in Taiwan

验证 WHO 2017 年分类标准并识别胰腺神经内分泌肿瘤患者的预后因素：台湾的真实世界经验

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.123900
Ho, Wei-Pang; Chou, Wen-Chi; Hsieh, Chia-Hsun; Hou, Ming-Mo; Shen, Wen-Chi; Huang, Pei-Wei; Wu, Chiao-En; Hsu, Chih-Chung; Chang, Wen-Cheng; Kuo, Yung-Chia; Hsu, Hung-Chih; Chang, Ching-Fu; Su, Po-Jung; Wu, Ren-Chin; Chen, Jen-Shi; Huang, Wen-Kuan
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Outcomes of Liposomal Irinotecan With 5-FU and Leucovorin in Patients With Metastatic Pancreatic Cancer and Borderline Performance Status

脂质体伊立替康联合5-氟尿嘧啶和亚叶酸钙治疗转移性胰腺癌且体能状态处于临界状态患者的疗效

期刊:
影响因子:
doi:10.21873/cdp.10430
Chang, Chieh-Ying; Chiu, Tai-Jan; Chen, Yen-Yang; Chen, Jen-Shi; Chou, Wen-Chi
胰腺癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 randomized, double-blind, placebo-controlled, phase 3 trial

纳武利尤单抗联合化疗治疗HER2阴性、既往未接受治疗、不可切除、晚期或复发性胃/胃食管交界处癌患者：ATTRACTION-4随机、双盲、安慰剂对照3期试验的3年随访结果

期刊:Gastric Cancer
影响因子:5.1
doi:10.1007/s10120-024-01535-0
Boku, Narikazu; Omori, Takeshi; Shitara, Kohei; Sakuramoto, Shinichi; Yamaguchi, Kensei; Kato, Ken; Kadowaki, Shigenori; Tsuji, Kunihiro; Ryu, Min-Hee; Oh, Do-Youn; Oh, Sang Cheul; Rha, Sun Young; Lee, Keun-Wook; Chung, Ik-Joo; Sym, Sun Jin; Chen, Li-Tzong; Chen, Jen-Shi; Bai, Li-Yuan; Nakada, Takashi; Hagihara, Shunsuke; Makino, Reina; Nishiyama, Eiji; Kang, Yoon-Koo
肿瘤
肿瘤免疫
HER2
发表日期：2024
文献求助 收藏